logo-loader

BioQ deal 'continues the momentum' says Clinigen chief Shaun Chilton

Published: 15:45 15 Dec 2016 GMT

Clinigen Group PLC (LON: CLIN) chief executive Shaun Chilton talks to Proactive about its Idis Global Access division signing a deal with BioQ Pharma to sell their pre-filled Ropivacaine Readyfusor for post-operative pain management. The deal allows Idis to distribute the product here in Europe (with the exception of France and Germany) prior to official marketing authorisation.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

2 hours, 6 minutes ago